Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0065 | 0.0087 | 1 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.0007 | 0.7552 |
Trichomonas vaginalis | beta-hexosaminidase B, putative | 0.0021 | 0.0009 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0021 | 0.0009 | 1 |
Trichomonas vaginalis | hypothetical protein | 0.0021 | 0.0009 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0021 | 0.0009 | 1 |
Trypanosoma brucei | mitogen-activated protein kinase 3, putative | 0.3119 | 0.5596 | 1 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0065 | 0.0087 | 0.0156 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0065 | 0.0087 | 0.0156 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0021 | 0.0009 | 1 |
Schistosoma mansoni | discoidin domain receptor | 0.0021 | 0.0009 | 0.1003 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0065 | 0.0087 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0021 | 0.0009 | 0.1003 |
Echinococcus granulosus | discoidin domain containing receptor 2 | 0.0021 | 0.0009 | 0.0016 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.002 | 0.0007 | 0.5 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.002 | 0.0007 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.3119 | 0.5596 | 1 |
Brugia malayi | P38 map kinase family protein 2 | 0.3119 | 0.5596 | 1 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.002 | 0.0007 | 0.0012 |
Toxoplasma gondii | F5/8 type C domain-containing protein | 0.0021 | 0.0009 | 0.0009 |
Schistosoma mansoni | septate junction protein | 0.0021 | 0.0009 | 0.1003 |
Schistosoma mansoni | btb and poz domain-containing protein | 0.0021 | 0.0009 | 0.1003 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.002 | 0.0007 | 0.0012 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0021 | 0.0009 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.3119 | 0.5596 | 1 |
Toxoplasma gondii | F5/8 type C domain-containing protein | 0.0021 | 0.0009 | 0.0009 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0021 | 0.0009 | 1 |
Loa Loa (eye worm) | TK/DDR protein kinase | 0.0151 | 0.0243 | 0.0236 |
Echinococcus multilocularis | Coagulation factor 5 8 type, C terminal | 0.0021 | 0.0009 | 0.0016 |
Leishmania major | mitogen-activated protein kinase 3, putative,map kinase 3, putative | 0.3119 | 0.5596 | 1 |
Mycobacterium leprae | PROBABLE CONSERVED TRANSMEMBRANE PROTEIN | 0.0021 | 0.0009 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0172 | 0.0281 | 0.0491 |
Toxoplasma gondii | PA14 domain-containing protein | 0.0021 | 0.0009 | 0.0009 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0021 | 0.0009 | 1 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.002 | 0.0007 | 0.0012 |
Toxoplasma gondii | F5/8 type C domain-containing protein | 0.0021 | 0.0009 | 0.0009 |
Echinococcus multilocularis | discoidin domain containing receptor 2 | 0.0021 | 0.0009 | 0.0016 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0065 | 0.0087 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.017 | 0.0276 | 0.027 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0021 | 0.0009 | 1 |
Echinococcus granulosus | discoidin domain receptor | 0.017 | 0.0276 | 0.0494 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0021 | 0.0009 | 1 |
Schistosoma mansoni | dock | 0.0021 | 0.0009 | 0.1003 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0021 | 0.0009 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.556 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0009 | 0.0002 |
Echinococcus granulosus | discoidin domain containing receptor 2 | 0.0021 | 0.0009 | 0.0016 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.002 | 0.0007 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0021 | 0.0009 | 1 |
Onchocerca volvulus | 0.0172 | 0.0281 | 1 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0021 | 0.0009 | 1 |
Echinococcus granulosus | discoidin domain containing receptor 2 | 0.0021 | 0.0009 | 0.0016 |
Brugia malayi | follicle stimulating hormone receptor | 0.0247 | 0.0416 | 0.0732 |
Toxoplasma gondii | exonuclease III APE | 0.002 | 0.0007 | 0.0007 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.3119 | 0.5596 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0065 | 0.0087 | 1 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.002 | 0.0007 | 1 |
Echinococcus multilocularis | discoidin domain containing receptor 2 | 0.0021 | 0.0009 | 0.0016 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0247 | 0.0416 | 0.041 |
Echinococcus multilocularis | nuclear receptor 2C2 associated protein | 0.0021 | 0.0009 | 0.0016 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0065 | 0.0087 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.3119 | 0.5596 | 1 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0021 | 0.0009 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0021 | 0.0009 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0009 | 0.0002 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0065 | 0.0087 | 1 |
Schistosoma mansoni | ap endonuclease | 0.002 | 0.0007 | 0.0757 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0021 | 0.0009 | 1 |
Loa Loa (eye worm) | CMGC/MAPK/P38 protein kinase | 0.3119 | 0.5596 | 0.5593 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0021 | 0.0009 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.556 | 1 | 1 |
Loa Loa (eye worm) | inward rectifying k channel family protein 1 | 0.556 | 1 | 1 |
Plasmodium vivax | LCCL domain-containing protein | 0.0021 | 0.0009 | 1 |
Echinococcus granulosus | mitogen activated protein kinase 14 | 0.3119 | 0.5596 | 1 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0065 | 0.0087 | 0.0156 |
Echinococcus multilocularis | discoidin domain containing receptor 2 | 0.0021 | 0.0009 | 0.0016 |
Echinococcus granulosus | mitogen activated protein kinase 11 | 0.3119 | 0.5596 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.3119 | 0.5596 | 1 |
Plasmodium vivax | LCCL domain-containing protein | 0.0021 | 0.0009 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0021 | 0.0009 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.3119 | 0.5596 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.002 | 0.0007 | 0.0012 |
Mycobacterium tuberculosis | Possible arabinofuranosyltransferase AftD | 0.0021 | 0.0009 | 0.0266 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0021 | 0.0009 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.002 | 0.0007 | 0.0012 |
Toxoplasma gondii | hypothetical protein | 0.556 | 1 | 1 |
Schistosoma mansoni | ap endonuclease | 0.002 | 0.0007 | 0.0757 |
Loa Loa (eye worm) | hypothetical protein | 0.0151 | 0.0243 | 0.0236 |
Echinococcus multilocularis | discoidin domain receptor | 0.0021 | 0.0009 | 0.0016 |
Trichomonas vaginalis | alpha-L-fucosidase, putative | 0.0021 | 0.0009 | 1 |
Trichomonas vaginalis | alpha-L-fucosidase, putative | 0.0021 | 0.0009 | 1 |
Schistosoma mansoni | discoidin domain receptor | 0.0021 | 0.0009 | 0.1003 |
Echinococcus granulosus | Coagulation factor 5 8 type C terminal | 0.0021 | 0.0009 | 0.0016 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0065 | 0.0087 | 0.0087 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.002 | 0.0007 | 0.0012 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.